2 Reasons Investors Should Not Short SpaceX Stock

The article argues that SpaceX's roughly 135x 2025 sales valuation is high but not necessarily a short opportunity because the company has real operating strength in Starlink and private space launches. It emphasizes that elevated multiples can persist for long periods, citing Palantir as an example, and warns short sellers about unlimited downside if the stock keeps rising. The piece is opinion-focused rather than news-driven, so near-term market impact is likely limited.

Analysis

The market is being asked to separate valuation from survivability, and that distinction matters here. The real signal is not that SpaceX is expensive; it is that private-market liquidity is still willing to underwrite an extremely long-duration growth asset with quasi-infrastructure characteristics. That makes the float less like a normal public short and more like a crowded consensus against a company whose primary risk is execution slippage over years, not quarters.

The second-order effect is on adjacent winners: any capital rotation into a "can’t short the best assets" framework tends to support other high-multiple scarcity names, especially PLTR, where the market has already normalized paying for optionality and mission-critical positioning. That also means public-market skeptics of mega-cap growth may be better served fading weaker business models rather than trying to time a multiple reset in the highest-quality asset in the group. In practice, short squeeze risk is amplified because there is no obvious catalyst that forces repricing in the near term.

The contrarian miss is that overvaluation may be the wrong variable; the more relevant question is whether future fundamental growth compresses the denominator fast enough to make today’s multiple look less extreme within 12-24 months. If launch cadence, satellite monetization, or defense-linked demand accelerates, the market can justify a lot more than current skeptics expect. The path of least resistance is still higher until either growth stalls or a better private-market funding alternative appears.

For traders, the setup argues for avoiding outright shorts and instead expressing skepticism through defined-risk structures or relative-value hedges. The opportunity is to own quality momentum while using any broad de-risking event to build exposure, rather than trying to call the top in a structurally scarce asset.

Key Decisions for Investors

• Do not short SPCX outright; if expressing bearishness, use a defined-risk put spread with 6-12 month tenor to cap unlimited upside risk.
• Pair trade: long PLTR / short a lower-quality high-multiple software name over the next 3-6 months, capturing the market’s willingness to pay for durable mission-critical growth while avoiding outright index beta.
• Buy any 10-15% pullback in SPCX only if private-market financing conditions remain supportive; use a staggered entry over 30-60 days to reduce timing risk.
• If forced to hedge a long-growth book, use index or sector hedges rather than single-name shorts; SPCX is too idiosyncratic and too supply-constrained for clean mean-reversion trades.
• Set a catalyst watch for any funding round, launch setback, or Starlink monetization miss; those are the only plausible near-term events that could compress the multiple within 1-2 quarters.